Principal Researcher: Professor Chris Jones Centres: The Institute of Cancer Research (ICR) – London. UK Background: The appearance of brain tumours in children is usually a devastating event. To date, there are few specific and effective therapies for this disease, and the average survival of a child patient after diagnosis is no longer than
Participation of the Federation of Parents of Children with Cancer and leading national hospitals treating children with cancer: Niño Jesús Hospital, Sant Joan de Déu Hospital, Vall d’Hebrón University Hospital. Principal Investigator: Mayte Moreno Centres: INVESTEN, Health care research unit belonging to the Carlos III Institute. SUMMARY Children with cancer often suffer pain due to
Investigador Principal: Dr. Enrique de Álava Casado. Centres: Virgen del Rocío Hospital, Seville and University of Valencia, Valencia. Background: Enrique de Álava’s laboratory is working on the molecular diagnosis of Ewing Sarcoma, a very aggressive type of bone tumour that mainly affects children and adolescents, especially during puberty. It has a high ability to spread rapidly and
Name of the Project: Research Project for MLL Leukaemia Principal Investigator: Dr Mireia Camós Centres: Sant Joan de Déu Hospital in Barcelona. Background: MLL (Mixed Lineage Leukemia) is a very aggressive type of leukaemia in children. While improvements have been made in the past few years in identifying the different types of MLL leukaemia
Principal Researchers: Dr. Antonio Pérez. Centres: La Paz Hospital, 12 de Octubre Hospital in Madrid. Timeline: Phase 1:2014-2016 , Phase 2: 2016-2018 Background: Children’s cancer has had no relevant treatment improvements in the past few years, in spite of its being the first cause of childhood death in our country. Treatments applied to adults are not suitable,
Principal Researcher: Dr. Antonio Pérez Martínez. Centres: Niño Jesús Children’s Hospital, CNIO (Spanish National Cancer Research Centre), La Paz University Hospital in Madrid, St. Jude Children’s Hospital, Memphis, EEUU. Background: Tumour cells appear when normal cells, after accumulating alterations every time they multiply, manage to evade the body’s control mechanisms, which control when, how and